Localized rifampicin albumin microspheres

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery Systems
• Biomaterials

Background:

• Rifampicin is a crucial antibiotic for treating tuberculosis.
• Developing effective drug delivery systems is essential for improving therapeutic outcomes and reducing side effects.
• Albumin microspheres offer potential for controlled drug release and targeted delivery.

Purpose of the Study:

• To prepare and optimize rifampicin-loaded albumin microspheres.
• To investigate the influence of process variables on microsphere characteristics and in vitro drug release.
• To evaluate the in vivo distribution and potential of these microspheres as a lung-targeted drug reservoir.

Main Methods:

• Preparation of rifampicin-loaded albumin microspheres using optimized process variables.
• Characterization of microsphere physical properties, including size and swelling behavior in buffer (pH 7.2) and serum.
• In vitro drug release studies.
• In vivo distribution studies in animal models to assess lung localization.

Main Results:

• Process variables were successfully optimized to control microsphere characteristics and drug release.
• Microspheres exhibited swelling in buffer and serum, indicating potential for controlled release.
• In vivo studies demonstrated significant lung localization (62%) of rifampicin when delivered via controlled-size microspheres.
• Albumin microspheres acted as an effective reservoir for achieving higher local drug concentrations in the lungs.

Conclusions:

• Rifampicin-loaded albumin microspheres can be effectively prepared and optimized for controlled drug delivery.
• The size of albumin microspheres is a critical factor in achieving targeted drug delivery to the lungs.
• These microspheres show promise as a reservoir system for enhancing local rifampicin concentrations in lung tissue, potentially improving tuberculosis treatment efficacy.